Exemplaires (1)
|
| TA 005477 | TA 6.2.3.1.4 GHO Q | Article/Périodique | Bibliothèque FARES | Tabac | Consultation sur place
Exclu du prêt |
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
| Titre : |
Quitting cigarettes completely or switching to smokeless tobacco : do US data replicate the Swedish results? |
| Type de document : |
texte imprimé |
| Auteurs : |
S-H Zhu, Auteur ; J B Wang, Auteur ; Anne Hartmann, Auteur |
| Editeur : |
BMJ Publishing Group |
| Année de publication : |
2009 |
| Collection : |
Tobacco Control num. Vol. 18 |
| Importance : |
p. 82-87 |
| Présentation : |
tab., graph. |
| Langues : |
Anglais (eng) |
| Catégories : |
[DIVERS] géographie:Amérique:Amérique du Nord:Etats-Unis
[DIVERS] géographie:Europe:Europe du Nord:Suède
[TABAC] chimie du tabac:tabac non fumé:tabac à sucer:snus
[TABAC] étude
[TABAC] prévention:stratégie:réduction du risque
|
| Index. décimale : |
TA 6.2.3.1.4 Autres substituts nicotiniques |
| Résumé : |
Background: Swedish male smokers are more likely than female smokers to switch to smokeless tobacco (snus) and males’ smoking cessation rate is higher than that of females. These results have fuelled international debate over promoting smokeless tobacco for harm reduction. This study examines whether similar results emerge in the United States, one of few other western countries where smokeless tobacco has long been widely available.
Methods: US data source: national sample in Tobacco Use Supplement to Current Population Survey, 2002, with 1-year follow-up in 2003. Analyses included adult self-respondents in this longitudinal sample (n = 15 056). Population-weighted rates of quitting smoking and switching to smokeless tobacco were computed for the 1-year period.
Results: Among US men, few current smokers switched to smokeless tobacco (0.3% in 12 months). Few former smokers turned to smokeless tobacco (1.7%). Switching between cigarettes and smokeless tobacco, infrequent among current tobacco users (<4%), was more often from smokeless to smoking. Men quit smokeless tobacco at three times the rate of quitting cigarettes (38.8% vs 11.6%, p<0.001). Overall, US men have no advantage over women in quitting smoking (11.7% vs 12.4%, p = 0.65), even though men are far likelier to use smokeless tobacco.
Conclusion: The Swedish results are not replicated in the United States. Both male and female US smokers appear to have higher quit rates for smoking than have their Swedish counterparts, despite greater use of smokeless tobacco in Sweden. Promoting smokeless tobacco for harm reduction in countries with ongoing tobacco control programmes may not result in any positive population effect on smoking cessation. |
| En ligne : |
https://tobaccocontrol.bmj.com/content/18/2/82 |
| Format de la ressource électronique : |
HTML |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=7962 |
|
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
(2001)
| Titre : |
A randomized controlled trial of a smoking cessation intervention based in community pharmacies |
| Type de document : |
texte imprimé |
| Auteurs : |
T.A. Maguire, Auteur ; J.C. McElnay, Auteur ; A. Drummond, Auteur |
| Editeur : |
Society for the study of addiction to alcohol and other drugs |
| Année de publication : |
2001 |
| Collection : |
Addiction num. 96 |
| Importance : |
p. 325-331 |
| Présentation : |
tab. |
| Langues : |
Anglais (eng) |
| Catégories : |
[DIVERS] géographie:Europe:Europe occidentale:Irlande
[TABAC] étude
[TABAC] prévention:santé:éducation pour la santé:rôle du professionnel de santé
[TABAC] sevrage tabagique:aide au sevrage:conseil de sevrage
|
| Index. décimale : |
TA 0.3.3 Dentistes et pharmaciens |
| Résumé : |
AIMS:
To evaluate whether a structured community pharmacy-based smoking cessation programme (the PAS model) would give rise to a higher smoking cessation rate compared with ad hoc advice from pharmacists.
DESIGN:
A randomized controlled trial comparing a structured intervention with usual care.
SETTING:
One hundred pharmacists working in community pharmacies in N. Ireland and 24 in London took part in the study and were each asked to enroll 12 smokers; 44% of pharmacists who were trained managed to recruit one or more smokers during the recruitment period of approximately 1 year.
PARTICIPANTS:
A total of 484 smokers were enrolled by the pharmacists and individually randomized into the PAS intervention group (N = 265) or the control group (N = 219).
INTERVENTION:
The PAS intervention involved a structured counselling programme, an information leaflet and a follow-up weekly for the first 4 weeks then monthly as needed.
MEASUREMENTS:
The primary outcome measure of this study was self-reported smoking cessation for 12 months with cotinine validation at the 12-month follow-up.
FINDINGS:
Of smokers in the PAS group, 14.3% (38) were abstinent up to 12 months compared with 2.7% (6) in the control group (p < 0.001 for the difference).
CONCLUSION:
The community pharmacy-based PAS smoking cessation service can be an effective method of helping people stop smoking when delivered by pharmacists willing to adopt this approach. |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8136 |
|
Exemplaires (1)
|
| TA 005713 | 0.3.3 MAG R | Article/Périodique | Bibliothèque FARES | Tabac | Consultation sur place
Exclu du prêt |
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
(2012)
| Titre : |
A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder |
| Type de document : |
texte imprimé |
| Auteurs : |
Jill M. William, Auteur ; Robert M. Anthenelli, Auteur ; Chad Morris, Auteur ; Joan Treadow, Auteur |
| Editeur : |
Physicians Postgraduate Press |
| Année de publication : |
2012 |
| Collection : |
The Journal of clinical psychiatry, ISSN 0160-6689 num. 73:5 |
| Importance : |
p. 654-660 |
| Présentation : |
tab. |
| Langues : |
Anglais (eng) |
| Catégories : |
[TABAC] étude
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:varénicline
[TABAC] tabagisme:pathologie:pathologie neurologique:schizophrénie
|
| Index. décimale : |
TA 6.2.3.2 Autres produits |
| Résumé : |
OBJECTIVE:
Effective smoking cessation treatments are needed for patients with schizophrenia, who, compared with the general population, have high rates of cigarette smoking and more difficulty quitting. We evaluated the safety and efficacy of varenicline for smoking cessation in outpatients with stable schizophrenia or schizoaffective disorder.
METHOD:
In this 12-week, randomized, double-blind, multicenter trial (May 8, 2008, to April 1, 2010), 127 smokers (≥ 15 cigarettes/d) with DSM-IV-confirmed schizophrenia or schizoaffective disorder received varenicline or placebo (2:1 ratio). The primary outcome was safety and tolerability of varenicline assessed by adverse events frequency and changes in ratings on the Positive and Negative Syndrome Scale and other psychiatric scales from baseline to 24 weeks. Abstinence was defined as no smoking 7 days prior to weeks 12 and 24, verified by carbon monoxide level.
RESULTS:
Eighty-four participants received varenicline; 43, placebo. At 12 weeks (end of treatment), 16/84 varenicline-treated patients (19.0%) met smoking cessation criteria versus 2/43 (4.7%) for placebo (P = .046). At 24 weeks, 10/84 (11.9%) varenicline-treated and 1/43 (2.3%) placebo-treated patients, respectively, met abstinence criteria (P = .090). Total adverse event rates were similar between groups, with no significant changes in symptoms of schizophrenia or in mood and anxiety ratings. Rates of suicidal ideation adverse events were 6.0% (varenicline) and 7.0% (placebo) (P = 1.0). There was 1 suicide attempt by a varenicline patient with a lifetime history of similar attempts and no completed suicides.
CONCLUSIONS:
Varenicline was well tolerated, with no evidence of exacerbation of symptoms, and was associated with significantly higher smoking cessation rates versus placebo at 12 weeks. Our findings suggest varenicline is a suitable smoking cessation therapy for patients with schizophrenia or schizoaffective disorder. |
| Note de contenu : |
Reprint with correction to page 658 |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8093 |
|
Exemplaires (1)
|
| TA 005642 | TA 6.2.3.2 WIL R | Article/Périodique | Bibliothèque FARES | Tabac | Consultation sur place
Exclu du prêt |
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
| Titre : |
Receptivity to tobacco advertising and susceptibility to tobacco products |
| Type de document : |
document électronique |
| Auteurs : |
John, P. Pierce, Auteur ; James Sargent, Auteur ; Martha, M. White, Auteur |
| Editeur : |
American Academy of Pediatrics |
| Année de publication : |
2018 |
| Collection : |
Pediatrics - Official journal of the American Academy of Pediatrics, ISSN Borzekowski num. 139 (6) |
| Importance : |
12 p. |
| Présentation : |
tab. |
| Langues : |
Anglais (eng) |
| Catégories : |
[DIVERS] géographie:Amérique:Amérique du Nord:Etats-Unis
[DIVERS] personne:famille:adolescent
[TABAC] chimie du tabac:tabac fumé:cigarette:cigarette électronique
[TABAC] chimie du tabac:tabac non fumé
[TABAC] économie du tabac:marketing:publicité
[TABAC] étude
|
| Index. décimale : |
TA 8.8 Publicité |
| Résumé : |
BACKGROUND AND OBJECTIVES:
Non–cigarette tobacco marketing is less regulated and may abstract
promote cigarette smoking among adolescents. We quantified receptivity to advertising for multiple tobacco products and hypothesized associations with susceptibility to cigarette smoking.
METHODS:
Wave 1 of the nationally representative PATH (Population Assessment of Tobacco and Health) study interviewed 10 751 adolescents who had never used tobacco. A stratified random selection of 5 advertisements for each of cigarettes, e-cigarettes, smokeless products, and cigars were shown from 959 recent tobacco advertisements. Aided recall was classified as low receptivity, and image-liking or favorite ad as higher receptivity. The main dependent variable was susceptibility to cigarette smoking.
RESULTS:
Among US youth, 41% of 12 to 13 year olds and half of older adolescents were receptive to at least 1 tobacco advertisement. Across each age group, receptivity to advertising was highest for e-cigarettes (28%–33%) followed by cigarettes (22%–25%), smokeless tobacco (15%–21%), and cigars (8%–13%). E-cigarette ads shown on television had the highest recall. Among cigarette-susceptible adolescents, receptivity to e-cigarette advertising (39.7%; 95% confidence interval [CI]: 37.9%–41.6%) was higher than for cigarette advertising (31.7%; 95% CI: 29.9%–33.6%). Receptivity to advertising for each tobacco product was associated with increased susceptibility to cigarette smoking, with no significant difference across products (similar odds for both cigarette and e-cigarette advertising; adjusted odds ratio = 1.22; 95% CI: 1.09–1.37).
CONCLUSIONS: A large proportion of US adolescent never tobacco users are receptive to
tobacco advertising, with television advertising for e-cigarettes having the highest recall.
Receptivity to advertising for each non–cigarette tobacco product was associated with
susceptibility to smoke cigarettes.
|
| En ligne : |
https://pediatrics.aappublications.org/content/early/2017/05/18/peds.2016-3353 |
| Format de la ressource électronique : |
Article en ligne |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9697 |
|
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
(2005)
Exemplaires (1)
|
| TA 001302 | TA 6.9 GIL D | Article/Périodique | Bibliothèque FARES | Tabac | Consultation sur place
Exclu du prêt |
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
| Titre : |
Relapse prevention interventions for smoking cessation |
| Type de document : |
texte imprimé |
| Auteurs : |
Peter Hajek, Auteur ; Lindsay F. Stead, Auteur ; Robert West, Auteur ; Martin J. Jarvis, Auteur ; T. Lancaster, Auteur |
| Année de publication : |
2009 |
| Importance : |
76 p. |
| Présentation : |
tab. |
| Langues : |
Anglais (eng) |
| Catégories : |
[TABAC] étude
[TABAC] sevrage tabagique:efficacité du sevrage:rechute
|
| Index. décimale : |
TA 6.5 Rechutes |
| Résumé : |
Contexte Un certain nombre de traitements peuvent aider les fumeurs à réussir leur tentative d’arrêt, mais bon nombre de ceux qui ont cessé de fumer au départ rechutent avec le temps. Plusieurs interventions ont été proposées pour aider à prévenir les rechutes. Objectifs Déterminer si des interventions spécifiques de prévention des rechutes réduisent la proportion de personnes ayant récemment cessé de fumer qui recommencent à fumer. Méthodes de recherche En août 2008, nous avons consulté le registre des essais du groupe de lutte contre le tabagisme dans le groupe Cochrane sur le tabac. maintien en titre, résumés ou mots-clés. Les critères de sélection Essais contrôlés randomisés ou quasi-randomisés d'interventions de prévention des rechutes avec un suivi minimum de six mois. nous incluaient les fumeurs qui avaient arrêté de fumer seuls ou suivaient une abstinence forcée ou qui participaient à des programmes de traitement. Nous avons inclus des essais comparant des interventions de prévention des rechutes à des interventions sans intervention ou comparant un programme de sevrage tabagique. avec des éléments supplémentaires de prévention des rechutes à un programme de cessation uniquement. Collecte et analyse de données Les études ont été examinées et les données extraites par un auteur et vérifiées par un second. Les désaccords ont été résolus par discussion ou par renvoi à un troisième auteur. Principaux résultats Cinquante-quatre études répondaient aux critères d'inclusion, mais étaient hétérogènes en termes de population et d'interventions. Nous avons examiné 36 études les abstentionnistes randomisés séparément des études randomisant les participants avant leur date d'arrêt. En regardant des études d'interventions comportementales qui ont randomisé les abstinents, nous n'avons détecté aucun bénéfice d'une rechute brève et «basée sur les compétences». méthodes de prévention pour les femmes qui avaient cessé de fumer en raison d'une grossesse ou pour les fumeuses en période d'abstinence forcée pendant l'hospitalisation ou l'entraînement militaire. Nous n’avons pas non plus détecté d’effets significatifs d’interventions comportementales lors d’essais chez des patients non sélectionnés. groupes de fumeurs qui ont cessé de fumer seuls ou avec un programme officiel. Parmi les essais randomisant les fumeurs avant leur date d'arrêt |
| En ligne : |
https://doi.org/10.1002/14651858.CD003999.pub6 |
| Format de la ressource électronique : |
PDF |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8828 |
|
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
(2008)
| Titre : |
Research effect on smoking quit rate of telling patients their lung age : step2quit randomised controlled trial |
| Type de document : |
texte imprimé |
| Auteurs : |
Gary Parkes, Auteur ; Trisha Greenhalgh, Auteur ; Mark Griffin, Auteur ; Richard Dent, Auteur |
| Editeur : |
BMJ Publishing Group |
| Année de publication : |
2008 |
| Collection : |
British Medical Journal num. 336 |
| Importance : |
7 p. |
| Présentation : |
tab., graph. |
| Langues : |
Anglais (eng) |
| Catégories : |
[DIVERS] géographie:Europe:Europe occidentale:Royaume-Uni:Angleterre
[TABAC] étude
[TABAC] sevrage tabagique
[TABAC] tabagisme:évaluation du tabagisme:test médical:spirométrie
|
| Index. décimale : |
TA 6.1 Généralités |
| Résumé : |
Objective To evaluate the impact of telling patients their estimated spirometric lung age as an incentive to quit smoking.
Design Randomised controlled trial.
Setting Five general practices in Hertfordshire, England.
Participants 561 current smokers aged over 35.
Intervention All participants were offered spirometric assessment of lung function. Participants in intervention group received their results in terms of “lung age” (the age of the average healthy individual who would perform similar to them on spirometry). Those in the control group received a raw figure for forced expiratory volume at one second (FEV1). Both groups were advised to quit and offered referral to local NHS smoking cessation services.
Main outcome measures The primary outcome measure was verified cessation of smoking by salivary cotinine testing 12 months after recruitment. Secondary outcomes were reported changes in daily consumption of cigarettes and identification of new diagnoses of chronic obstructive lung disease.
Results Follow-up was 89%. Independently verified quit rates at 12 months in the intervention and control groups, respectively, were 13.6% and 6.4% (difference 7.2%, P=0.005, 95% confidence interval 2.2% to 12.1%; number needed to treat 14). People with worse spirometric lung age were no more likely to have quit than those with normal lung age in either group. Cost per successful quitter was estimated at £280 (€366, $556). A new diagnosis of obstructive lung disease was made in 17% in the intervention group and 14% in the control group; a total of 16% (89/561) of participants.
Conclusion Telling smokers their lung age significantly improves the likelihood of them quitting smoking, but the mechanism by which this intervention achieves its effect is unclear. |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8133 |
|
Exemplaires (1)
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
(17/02/2009)
Exemplaires (1)
|
| TA 002319 | TA 3.2.2.3. VUA R | Article/Périodique | Bibliothèque FARES | Tabac | Consultation sur place
Exclu du prêt |
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
| Titre : |
Retrospective assessment of potential negative synergistic effects of varicocele and tobacco use on ultrastructural sperm morphology |
| Type de document : |
document électronique |
| Auteurs : |
G. Collodel, Auteur ; S. Capitani, Auteur ; F. Iacoponi, Auteur ; M.G. Federico, Auteur ; N.A. Pascarelli, Auteur ; E. Moretti, Auteur |
| Editeur : |
New-York [États-Unis] : Elsevier Science |
| Année de publication : |
2009 |
| Collection : |
Urology, ISSN 1527-9995 num. 74(4) |
| Importance : |
p.794-799 |
| Langues : |
Anglais (eng) |
| Catégories : |
[TABAC] étude
[TABAC] tabagisme:effet du tabac:altération de la fonction sexuelle:effet sur la fertilité
|
| Index. décimale : |
TA 3.2.2.6 Effets métaboliques et biologiques |
| Résumé : |
Objectives: To investigate, in a retrospective study, whether smoking cigarettes increases the effect of varicocele on sperm morphology.
Methods: The semen quality of 2 groups of patients with varicocele were compared, those who smoked (n = 121) and those who did not (n = 158). The semen parameters were evaluated, and sperm morphology was assessed using transmission electron microscopy and quantitatively elaborated (fertility index, immaturity, necrosis, and apoptosis percentages).
Results: In the smoker and nonsmoker varicocele-associated cases, sperm motility and the results from transmission electron microscopy analysis were significantly impaired compared with controls. However, a nonsignificant difference was detected when the semen parameters were compared. Subsequently, we divided the patients into 4 groups: mild (> or = 1 but < or = 10 cigarettes/d), moderate (>10 but <20 cigarettes/d), and heavy (> or = 20 cigarettes/d) smokers and a group of randomly chosen nonsmoker patients with varicocele. The sperm motility, sperm concentration, and fertility index decreased and the percentage of sperm pathologic features increased as the number of cigarettes smoked daily increased.
Conclusions: A detrimental effect of cigarette smoking (>10 cigarettes/d) associated with varicocele on sperm motility and morphology was observed. Because much of reduced fecundity associated with smoking may be reversed within 1 year of cessation, as reported in published studies, effective interventions targeted at helping patients quit smoking should be addressed for the benefit of general health and fertility.
|
| En ligne : |
https://doi.org/10.1016/j.urology.2009.01.078 |
| Format de la ressource électronique : |
Article en ligne |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10102 |
|
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
(2001)
| Titre : |
Les revenus fiscaux issus de la vente de tabac aux jeunes en France |
| Type de document : |
texte imprimé |
| Auteurs : |
L. Josseran, Auteur |
| Editeur : |
Santé publique |
| Année de publication : |
2001 |
| Collection : |
Santé publique num. 13 (1) |
| Importance : |
p.27-33 |
| Langues : |
Français (fre) |
| Catégories : |
[DIVERS] géographie:Europe:Europe occidentale:France
[DIVERS] personne:par âge:jeune
[TABAC] étude
[TABAC] législation:taxation
[TABAC] prévention
|
| Index. décimale : |
TA 8.6 Apport financier à l'économie et à l'État |
| Résumé : |
Cet article étudie le montant des recettes fiscales pour l'Etat venant de la consommation de tabac des jeunes en France en 1997, comparées aux moyens de prévention mis en oeuvre cette même année. Les recettes fiscales sont estimées à partir de la prévalence du tabagisme par classe d'âge, de la démographie de ces classes, du nombre de cigarettes fumées quotidiennement dans ces classes d'âge, du prix moyen d'un paquet de cigarettes et de la taxation sur le tabac. Près de 1,7 million de jeunes fumaient.Ils ont consommé 240 millions de paquest de cigarettes. Cette vente a représenté 4,760 milliards de francs français (725 millions d'euros), soit 3,615 milliards de FF (551 millions € ) de taxes pour l'Etat, 0,380 milliard FF (57 millions €) pour les débitants du tabac et 0,762 milliard FF (116 millions €) pour les fabricants. La même année, la prévention représentait moins de 0,5 FF (0,075 €) par an et habitant, un des ratios les plus faibles des pays développés. |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2968 |
|
Exemplaires (1)
|
| TA 002283 | TA 8.6 JOS R | Article/Périodique | Bibliothèque FARES | Tabac | Consultation sur place
Exclu du prêt |
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
(2010-09)
| Titre : |
A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities |
| Type de document : |
texte imprimé |
| Auteurs : |
Evelina Zimovetz, Auteur ; Koo Wilson, Auteur ; Miny Samuel, Auteur ; Stephen, M. Beard, Auteur |
| Année de publication : |
2010-09 |
| Importance : |
1 |
| Langues : |
Anglais (eng) |
| Catégories : |
[TABAC] étude
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:varénicline
[TABAC] tabagisme:aspect économique:coût du tabagisme:coût pour le fumeur
|
| Index. décimale : |
TA 6.2.3 Approche pharmacologique |
| Résumé : |
RATIONALE:
This review aims to examine economic evaluations of varenicline, to compare the reported cost-effectiveness of varenicline with that of treatments for major smoking-related diseases and to evaluate the findings for decision making.
METHODS:
A literature search was performed to identify published articles in English indexed in MEDLINE and the Cochrane Library (Issue 1, 2009), which includes the Economic Evaluation Database. Additional sources also were searched to identify unpublished varenicline studies, including conference abstracts. The search for varenicline studies was limited from 2006 to October 2009; searches for all other types of studies were limited from 1990 to October 2009.
RESULTS:
The search yielded a total of 20 relevant economic evaluations of varenicline. In addition, 37 reviews of economic evaluations in chronic obstructive pulmonary disease, non-small cell lung cancer and cardiovascular disease, as well as studies evaluating the impact of economic rewarding were considered in this review. From these identified economic evaluations, the incremental cost-effectiveness ratios for varenicline ranged from dominance (more effective and cost saving) to €18,582 per quality-adjusted life-year (including indirect costs). These estimates appeared substantially lower when compared with incremental cost-effectiveness ratios reported for secondary prevention of smoking-related diseases, which in some cases were as high as €66,218 per quality-adjusted life-year.
CONCLUSIONS:
Varenicline appears to be cost-effective from the perspective of both health care payers and employers, because of reduced health care consumption and costs. The cost-effectiveness of varenicline also compares favourably to that of interventions recommended for the treatment and prevention of smoking-related diseases. |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8042 |
|
Exemplaires (1)
|
| TA 005592 | TA 6.2.3 ZIM R | Article/Périodique | Bibliothèque FARES | Tabac | Consultation sur place
Exclu du prêt |
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
(2007)
Exemplaires (1)
|
| TA 001487 | TA 3.2.2.2.1 CRU R | Article/Périodique | Bibliothèque FARES | Tabac | Consultation sur place
Exclu du prêt |
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
(2008)
| Titre : |
Safety report on the Ruyan(R) e-cigarette |
| Type de document : |
document électronique |
| Auteurs : |
Murray Laugesen, Auteur |
| Editeur : |
Health New Zealand |
| Année de publication : |
2008 |
| Importance : |
23 p. |
| Langues : |
Anglais (eng) |
| Catégories : |
[TABAC] chimie du tabac:constituant:alcaloïde:nicotine
[TABAC] chimie du tabac:tabac fumé:cigarette:cigarette électronique
[TABAC] étude
|
| Index. décimale : |
TA 1.1.1 Cigarettes (« normales », électroniques, aromatisées,…) |
| Résumé : |
La cigarette électronique Ruyan(R) est concue pour être une alternative saine au tabagisme, et sous un grand nombre d'aspects, elle semble parvenir à ses fins. Son électronique sophisitiquée vaporise, séparément pour chaque bouffée, de très petites quantités de nicotine dissolues dans du propylene glycol, deux petite molécules bien connues ayant des profils de sécurité excellents - dans un bon aérosol. Chaque bouffée contient d'un tiers à la moitié de la nicotine d'une bouffée de cigarette au tabac. Le liquide de la cartouche est sans tabac et aucune combustion n'a lieu. Une fois sur le marché, le maintien de son profil de sécurité dépend : 1) de bonnes pratiques de fabrication et d'une pureté pharmaceutique de la nicotine et du propylene glycol utilisés dans le liquide de la cartouche 2) de la prévention d'un usage partagé dont pourrait résulter une infection croisée. Début 2008, l'unité de recherche des essais cliniques de l'Université d'Auckland est en train de tester l'efficacité de l'e-cigarette en ce qui concerne l'augmentation du taux de nicotine dans le sang et sur la réduction du manque de la cigarette. |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10000 |
|
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
| Titre : |
Secondhand smoke exposure in hospitality venues in Europe |
| Type de document : |
texte imprimé |
| Auteurs : |
Maria J. Lopez, Auteur ; M. Nebot, Auteur ; Marco Albertini, Auteur ; Pierre Birkui, Auteur |
| Année de publication : |
2008 |
| Importance : |
p. 1469-1472 |
| Présentation : |
tab. |
| Langues : |
Anglais (eng) |
| Catégories : |
[DIVERS] géographie:Europe
[TABAC] étude
[TABAC] législation:milieu réglementé:horeca
[TABAC] législation:milieu réglementé:lieu public
[TABAC] tabagisme:tabagisme passif
|
| Index. décimale : |
TA 7.8 Lieux non-fumeurs |
| Résumé : |
Abstract
BACKGROUND:
Although in the last few years some European countries have implemented smoking bans in hospitality venues, the levels of secondhand smoke (SHS) in this occupational sector could still be extremely high in most countries.
OBJECTIVE:
The aim of this study was to assess exposure to SHS in hospitality venues in 10 European cities.
METHODS:
We included 167 hospitality venues (58 discotheques and pubs, 82 restaurants and cafeterias, and 27 fast-food restaurants) in this cross-sectional study. We carried out fieldwork in 10 European cities: Vienna (Austria), Paris (France), Athens (Greece), Florence and Belluno (Italy), Galway (Ireland), Barcelona (Spain), Warsaw and Lublin (Poland), and Bratislava (Slovak Republic). We measured vapor-phase nicotine as an SHS marker.
RESULTS:
We analyzed 504 samples and found nicotine in most samples (97.4%). We found the highest median concentrations in discos/pubs [32.99 microg/m(3); interquartile range (IQR), 8.06-66.84 microg/m(3)] and lower median concentrations in restaurants/cafeterias (2.09 microg/m(3); IQR, 0.49-6.73 microg/m(3)) and fast-food restaurants (0.31 microg/m(3); IQR, 0.11-1.30 microg/m(3)) (p < 0.05). We found differences of exposure between countries that may be related to their smoking regulations. Where we sampled smoking and nonsmoking areas, nicotine concentrations were significantly lower in nonsmoking areas.
CONCLUSIONS:
Hospitality venues from European cities without smoking regulations have very high levels of SHS exposure. Monitoring of SHS on a regular basis as well as a total smoking ban in hospitality sector would be needed. |
| En ligne : |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592265/ |
| Format de la ressource électronique : |
HTML |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8084 |
|
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
| Titre : |
Selection homophily and peer influence for adolescents’ smoking and vaping norms and outcomes in high and middle-income settings |
| Type de document : |
document électronique |
| Auteurs : |
Jennifer M. Murray, Auteur ; Sharon, C. Sánchez-Franco, Auteur ; Olga L. Sarmiento, Auteur |
| Editeur : |
Orange [Etats-Unis] : Chapman Univertsity |
| Année de publication : |
2023 |
| Collection : |
Humanities and social sciences communications |
| Importance : |
35 p. |
| Présentation : |
ill, tab., graph |
| Langues : |
Anglais (eng) |
| Catégories : |
[DIVERS] géographie:Europe:Europe occidentale:Royaume-Uni
[DIVERS] personne:famille:adolescent
[TABAC] CANDIDATS:e-cigarette
[TABAC] étude
[TABAC] prévention
[TABAC] tabagisme:aspect psychologique:comportement
[TABAC] tabagisme:aspect social:rôle de la famille
|
| Mots-clés : |
Influence pas les pairs - Colombie |
| Index. décimale : |
TA 4.1.2 Influence sur le mode de vie |
| Résumé : |
The MECHANISMS study investigates how social norms for adolescent smoking and vaping are transmitted through school friendship networks, and is the first study to use behavioral economics methodology to assess smoking-related social norms. Here, we investigate the effects of selection homophily (the tendency to form friendships with similar peers) and peer influence (a social process whereby an individual’s behavior or attitudes are affected by peers acting as reference points for the individual) on experimentally measured smoking and vaping norms, and other smoking outcomes, in adolescents from high and middle-income settings.
Full school year groups in six secondary schools in Northern Ireland (United Kingdom) and six secondary schools in Bogotá (Colombia) participated (n = 1344/1444,
participation = 93.1%, target age 12–13 years). Over one semester, pupils received one previously tested school-based smoking prevention program (ASSIST or Dead Cool). Outcomes included experimentally measured smoking/vaping norms, self-report and objectively measured smoking behavior, and self-report smoking norms, intentions, susceptibility, attitudes, and psycho-social antecedents. We investigated selection homophily and peer influence using regressions and SIENA modeling. Regression results demonstrate lagged and contemporaneous selection homophily (odds ratios [ORs] = 0.87–1.26, p ≤ 0.01), and peer influence effects for various outcomes from average responses of friends, school classes, or school year groups (standardized coefficients [βs] = 0.07–0.55, ORs = 1.14–1.31, p ≤ 0.01).
SIENA models showed that comparable proportions of smoking/vaping-based similarity between friends were due to selection homophily (32.8%) and peer influence (39.2%). A higher percentage of similarity between friends was due to selection homophily and/or peer influence for ASSIST schools compared to Dead Cool. Selection homophily was also more important in Bogotá, whilst peer influence was stronger in Northern Ireland. These findings support using social norms strategies in adolescent smoking prevention interventions. Future research should consider selection homophily and social influence jointly, and examine whether these findings translate to other high and low-middle-income settings with varying cultures and norms.
A full |
| En ligne : |
https://doi.org/10.1057/s41599-023-02124-9 |
| Format de la ressource électronique : |
Article en ligne |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10251 |
|
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
(03/09/2013)
Exemplaires (1)
|
| TA 006942 | TA 6.2 PFI S | Article/Périodique | Bibliothèque FARES | Tabac | Consultation sur place
Exclu du prêt |
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
(2006)
| Titre : |
Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healty smokers and no smokers |
| Type de document : |
texte imprimé |
| Auteurs : |
Helene Faessel, Auteur ; Bill J. Smith, Auteur ; Megan A. Gibbs, Auteur |
| Editeur : |
Wiley |
| Année de publication : |
2006 |
| Collection : |
Journal of Clinical Pharmacology, ISSN 0091-2700 num. Vol 46 |
| Importance : |
p. 991-998 |
| Présentation : |
tab., graph. |
| Langues : |
Anglais (eng) |
| Catégories : |
[TABAC] étude
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:varénicline
|
| Index. décimale : |
TA 6.2.3.1.4 Autres substituts nicotiniques |
| Résumé : |
Varenicline is a novel and selective alpha4beta2 nicotinic receptor partial agonist that is under development for smoking cessation. The primary objectives of this double-blind, placebo-controlled, single-dose, dose-escalation study were to determine the clinical pharmacology of single doses of varenicline in healthy smokers and nonsmokers under fed and fasted conditions and to determine the clinical pharmacology of varenicline administered in the morning and in the evening to smokers. Within each subject group, 4 subjects were randomized to varenicline and 2 subjects to placebo. Subjects received one single oral administration of varenicline or placebo: 6 doses (0.01, 0.03, 0.1, 0.3, 1.0, and 3.0 mg) were investigated in nonsmokers and 7 doses in smokers (0.01, 0.03, 0.1, 0.3, 1.0, 3.0, and 10.0 mg). Varenicline was well tolerated after single doses up to 3.0 mg in smokers and 1.0 mg in nonsmokers. Nausea and vomiting at doses above 3.0 mg in smokers and 1.0 mg in nonsmokers were dose limiting. Systemic exposure to varenicline and pharmacokinetic variability were similar between smokers and nonsmokers. Coadministration with food, smoking restriction, and time-of-day dosing did not affect the pharmacokinetics of varenicline. |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=7945 |
|
Exemplaires (1)
|
| TA 005486 | TA 6.2.3.1.4 FAE S | Article/Périodique | Bibliothèque FARES | Tabac | Consultation sur place
Exclu du prêt |
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
| Titre : |
Six-month and one-year effects of Project EX-4 : A classroom-based smoking prevention and cessation intervention program |
| Type de document : |
texte imprimé |
| Auteurs : |
Steve Sussman, Auteur ; James Miyano, Auteur ; Louise Ann Rohrbach, Auteur ; Clyde W. Dent, Auteur ; Ping Sun, Auteur |
| Editeur : |
Paris [France] : Elsevier |
| Année de publication : |
2007 |
| Collection : |
Addictive Behaviours |
| Note générale : |
Dans la bibliothèque virtuelle (articles scientifiques) |
| Catégories : |
[DIVERS] personne:famille:adolescent
[TABAC] étude
[TABAC] législation:milieu réglementé:milieu scolaire
[TABAC] prévention
[TABAC] sevrage tabagique
|
| Index. décimale : |
TA 5.3.1 Programmes scolaire de prévention |
| Résumé : |
Objective: This study evaluated the efficacy of a version of Project EX that was adapted for implementation in the classroom context (Project EX-4). This paper reports the program outcomes based on pretest, six-month, and one year follow-up surveys. Methods: An 8 session classroom-based curriculum was tested with a clustered randomized controlled trial that involved a total of 1097 students in 6 program and 6 control alternative high schools. Weekly and monthly smoking was assessed at the three time points. Outcome effects were analyzed with multi-level random coefficients models. Results: Students in the programcondition experienced a greater reduction in weekly smoking and monthly smoking, at 6-and-12-month follow-ups. The net change varied between -5.1% and -7.6%, comparing the programcondition to the control condition. Conclusions: The implementation of Project EX in a classroom setting produced decreases in smoking among students in the program, relative to those in the standard care control condition. It is likely that a classroom-based smoking prevention/cessation program can lead to lower overall smoking prevalence than a cessation program that is implemented in a school-based smoking cessation clinic format. |
| En ligne : |
https://doi.org/10.1016/j.addbeh.2007.06.016 |
| Format de la ressource électronique : |
Article en ligne |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=1422 |
|
Exemplaires (1)
|
| TA 002087 | TA 5.3.1 SUS S | Article/Périodique | Bibliothèque FARES | Tabac | Consultation sur place
Exclu du prêt |
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
(2001)
Exemplaires (1)
|
| TA 005286 | 6.2.2 MIL S | Article/Périodique | Bibliothèque FARES | Tabac | Consultation sur place
Exclu du prêt |
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
(2004)
Exemplaires (1)
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
(2007)
| Titre : |
Smokers’ melanosis in a Nigerian population : a preliminary study |
| Type de document : |
texte imprimé |
| Auteurs : |
O. Solomon, Auteur ; Kofo Winfuke-Savage, Auteur ; Patricia Ayanbandejo, Auteur ; Sunny O. Jeboda, Auteur |
| Editeur : |
Jaypee Brothers Medical Publishers |
| Année de publication : |
2007 |
| Collection : |
Journal of Contemporary Dental Practice num. 6 (5) |
| Importance : |
p.1 |
| Note générale : |
Dans la bibliothèque virtuelle (articles scientifiques) |
| Langues : |
Anglais (eng) |
| Catégories : |
[TABAC] étude
[TABAC] tabagisme
[TABAC] tabagisme:pathologie
|
| Index. décimale : |
TA 3.2.2.6 Effets métaboliques et biologiques |
| Résumé : |
Terms relating to pigmentation of the oral mucosa include physiologic (racial) pigmentation, oral pigmented nevi, oral melanotic maculae, melanoma, and smokers’ melanosis. The literature is replete with studies about oral mucosal pigmentation which is thought to result from melanin incontinence. The documented etiological factors are both local and systemic and include hormones, drugs, smoking, and idiopathic causes. This study investigated the prevalence of melanosis among Nigerian smokers and controls who were non-smokers. |
| Permalink : |
https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2760 |
|
Exemplaires (1)
|
| TA 001489 | TA 3.2.2.6 SOL S | Article/Périodique | Bibliothèque FARES | Tabac | Consultation sur place
Exclu du prêt |
Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Ajouter le résultat dans votre panier Affiner la recherche
